Stock IPSC CENTURY THERAPEUTICS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Sector Chart Century Therapeutics, Inc.

Equities

IPSC

US15673T1007

Market Closed - Nasdaq
Other stock markets
 01:30:00 29/06/2024 am IST 		5-day change 1st Jan Change
2.55 USD +0.79% Intraday chart for Century Therapeutics, Inc. -10.84% -23.19%
18/06 Century Therapeutics Proposes Secondary Offering of 7.87 Million Shares MT
17/06 Piper Sandler Adjusts Price Target on Century Therapeutics to $12 From $9, Maintains Overweight Rating MT
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes

Sector Other Biotechnology & Medical Research

Capi. Sales growth Profitability Finances EV / Sales P/E ratio
CENTURY THERAPEUTICS, INC. Stock Century Therapeutics, Inc.
 215M - - -
MODERNA, INC. Stock Moderna, Inc.
 45.51B -
LONZA GROUP AG Stock Lonza Group AG
 39.36B
IQVIA HOLDINGS INC. Stock Iqvia Holdings Inc.
 38.52B
ALNYLAM PHARMACEUTICALS, INC. Stock Alnylam Pharmaceuticals, Inc.
 30.74B -
CELLTRION, INC. Stock Celltrion, Inc.
 26.03B
  1. Stock Market
  2. Equities
  3. IPSC Stock
  4. Charts Century Therapeutics, Inc.
  5. Sector Chart